Companies:
49,847
Total Market Cap:
139471428529843.49
Global Rank
#1522
Country Rank
#51
Market Cap
13.25 B
Price
30.69
Change (%)
3.09%
Volume
3.96 M
Smith & Nephew plc's latest marketcap:
13.25 B
As of 07/10/2025, Smith & Nephew plc's market capitalization has reached $13.25 B. According to our data, Smith & Nephew plc is the 1522th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 13.25 B |
| Revenue (ttm) | 5.81 B |
| Net Income (ttm) | 412 M |
| Shares Out | 873.49 M |
| EPS (ttm) | 0.47 |
| Forward PE | 15.11 |
| Ex-Dividend Date | 03/28/2025 |
| Earnings Date | 07/31/2025 |
Market Cap Chart
Data Updated: 07/10/2025
Smith & Nephew plc's yearly market capitalization.
Smith & Nephew plc has seen its market value grow from $5.43 B to $13.25 B since 2002, representing a total increase of 143.92% and an annual compound growth rate (CAGR) of 4.04%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/10/2025 | $13.25 B | 21.81% | 1522 |
| 12/31/2024 | $10.79 B | -9.89% | 1612 |
| 12/29/2023 | $11.97 B | 0.59% | 1390 |
| 12/30/2022 | $11.9 B | -22.3% | 1311 |
| 12/31/2021 | $15.32 B | -17.93% | 1263 |
| 12/31/2020 | $18.66 B | -12.54% | 941 |
| 12/31/2019 | $21.34 B | 28.18% | 670 |
| 12/31/2018 | $16.65 B | 5.25% | 684 |
| 12/29/2017 | $15.82 B | 14.9% | 815 |
| 12/30/2016 | $13.77 B | -18.67% | 752 |
Company Profile
About Smith & Nephew plc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services globally, with operations in the UK, the US, and other international markets.
Business Segments
- Orthopaedics: Offers knee and hip implants, trauma and extremities products, and other reconstruction solutions.
- Sports Medicine & ENT: Provides joint repair products, arthroscopic enabling technologies, and ear, nose, and throat solutions.
- Advanced Wound Management: Delivers wound care products, bioactives, regenerative medicine, and wound therapy devices.
Key Products & Services
- Knee and hip replacement implants.
- Sports medicine solutions for soft tissue injuries and degenerative conditions.
- Advanced wound care for acute and chronic wounds, ulcers, and burns.
- Regenerative medicine products, including skin and bone graft substitutes.
- Negative pressure wound therapy and hydrosurgery systems.
The company serves healthcare providers and was founded in 1856, with its headquarters located in Watford, UK.
Frequently Asked Questions
-
What is Smith & Nephew plc's (SNN) current market cap?As of 07/10/2025, Smith & Nephew plc (including the parent company, if applicable) has an estimated market capitalization of $13.25 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Smith & Nephew plc (SNN) rank globally by market cap?Smith & Nephew plc global market capitalization ranking is approximately 1522 as of 07/10/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.